OBJECTIVES: To determine clinic-level and individual-level correlates of viral suppression among HIV-positive adolescents and young adult (AYA) aged 10-24 years receiving antiretroviral treatment (ART). DESIGN: Multilevel cross-sectional analysis using viral load data and facility surveys from HIV treatment programs throughout Kenya. METHODS: We abstracted medical records of AYA in HIV care, analyzed the subset on ART for more than 6 months between January 2016 and December 2017, and collected information on services at each clinic. Multilevel logistic regression models were used to determine correlates of viral suppression at most recent assessment. RESULTS: In 99 HIV clinics, among 10 096 AYA on ART more than 6 months, 2683 (27%) had unsuppressed viral load at last test. Among 16% of clinics, more than 80% of AYA were virally suppressed. Clinic-level correlates of individual viral suppression included designated adolescent spaces [aOR: 1.32, 95% CI (1.07-1.63)] and faster viral load turnaround time [aOR: 1.06 (95% CI 1.03-1.09)]. Adjusting for clinic-level factors, AYA aged 10-14 and 15-19 years had lower odds of viral suppression compared with AYA aged 20-24 years [aOR: 0.61 (0.54-0.69) and 0.59 (0.52-0.67], respectively. Compared with female patients, male patients had lower odds of viral suppression [aOR: 0.69 (0.62-0.77)]. Compared with ART duration of 6-12 months, ART for 2-5, above 5-10 or more than 10 years was associated with poor viral suppression (P < 0.001). CONCLUSION: Dedicated adolescent space, rapid viral load turnaround time, and tailored approaches for male individuals and perinatally infected AYA may improve viral suppression. Routine summarization of viral load suppression in clinics could provide benchmarking to motivate innovations in clinic-AYA and individual-AYA care strategies.
OBJECTIVES: To determine clinic-level and individual-level correlates of viral suppression among HIV-positive adolescents and young adult (AYA) aged 10-24 years receiving antiretroviral treatment (ART). DESIGN: Multilevel cross-sectional analysis using viral load data and facility surveys from HIV treatment programs throughout Kenya. METHODS: We abstracted medical records of AYA in HIV care, analyzed the subset on ART for more than 6 months between January 2016 and December 2017, and collected information on services at each clinic. Multilevel logistic regression models were used to determine correlates of viral suppression at most recent assessment. RESULTS: In 99 HIV clinics, among 10 096 AYA on ART more than 6 months, 2683 (27%) had unsuppressed viral load at last test. Among 16% of clinics, more than 80% of AYA were virally suppressed. Clinic-level correlates of individual viral suppression included designated adolescent spaces [aOR: 1.32, 95% CI (1.07-1.63)] and faster viral load turnaround time [aOR: 1.06 (95% CI 1.03-1.09)]. Adjusting for clinic-level factors, AYA aged 10-14 and 15-19 years had lower odds of viral suppression compared with AYA aged 20-24 years [aOR: 0.61 (0.54-0.69) and 0.59 (0.52-0.67], respectively. Compared with female patients, male patients had lower odds of viral suppression [aOR: 0.69 (0.62-0.77)]. Compared with ART duration of 6-12 months, ART for 2-5, above 5-10 or more than 10 years was associated with poor viral suppression (P < 0.001). CONCLUSION: Dedicated adolescent space, rapid viral load turnaround time, and tailored approaches for male individuals and perinatally infected AYA may improve viral suppression. Routine summarization of viral load suppression in clinics could provide benchmarking to motivate innovations in clinic-AYA and individual-AYA care strategies.
Authors: Walter Kipp; Arif Alibhai; L Duncan Saunders; Ambikaipakan Senthilselvan; Amy Kaler; Joseph Konde-Lule; Joa Okech-Ojony; Tom Rubaale Journal: AIDS Care Date: 2010-03
Authors: Bradley C Fetzer; Bavon Mupenda; Jean Lusiama; Faustin Kitetele; Carol Golin; Frieda Behets Journal: AIDS Patient Care STDS Date: 2011-08-08 Impact factor: 5.078
Authors: Shoshana Y Kahana; Maria Isabel Fernandez; Patrick A Wilson; Jose A Bauermeister; Sonia Lee; Craig M Wilson; Lisa B Hightow-Weidman Journal: J Acquir Immune Defic Syndr Date: 2015-02-01 Impact factor: 3.731
Authors: Esther Nasuuna; Joanita Kigozi; Lillian Babirye; Alex Muganzi; Nelson K Sewankambo; Damalie Nakanjako Journal: BMC Public Health Date: 2018-08-22 Impact factor: 3.295
Authors: Casey Adams; Millicent Kiruki; Robinson Karuga; Lilian Otiso; Susan M Graham; Kristin M Beima-Sofie Journal: BMC Public Health Date: 2022-06-30 Impact factor: 4.135
Authors: Jason Johnson-Peretz; Sarah Lebu; Cecilia Akatukwasa; Monica Getahun; Theodore Ruel; Joi Lee; James Ayieko; Florence Mwangwa; Lawrence Owino; Anjeline Onyango; Irene Maeri; Frederick Atwine; Edwin D Charlebois; Elizabeth A Bukusi; Moses R Kamya; Diane V Havlir; Carol S Camlin Journal: J Int AIDS Soc Date: 2022-07 Impact factor: 6.707
Authors: Isaac Tsikhutsu; Margaret Bii; Nicole Dear; Kavitha Ganesan; Alex Kasembeli; Valentine Sing'oei; Kevin Rombosia; Christopher Ochieng; Priyanka Desai; Vanessa Wolfman; Peter Coakley; Elizabeth H Lee; Patrick W Hickey; Jeffrey Livezey; Patricia Agaba Journal: Clin Infect Dis Date: 2022-09-29 Impact factor: 20.999
Authors: Gillian Dougherty; Steve Akoth; Mark Hawken; Isaac Leting; Redempta Mutei; Catherine Ngugi; Doris Naitore; Fatima Tsiouris; Anne Wakoli; Lauren Walker; Miriam Rabkin Journal: BMJ Open Qual Date: 2022-08
Authors: Kaymarlin Govender; Richard Gregory Cowden; Patrick Nyamaruze; Russell Murray Armstrong; Luann Hatane Journal: Front Public Health Date: 2020-10-19
Authors: Hellen M Okinyi; Cyrus M Wachira; Kate S Wilson; Margaret N Nduati; Alvin D Onyango; Caren W Mburu; Irene W Inwani; Tamara L Owens; David E Bukusi; Grace C John-Stewart; Dalton C Wamalwa; Pamela K Kohler Journal: J Int Assoc Provid AIDS Care Date: 2022 Jan-Dec